Shelly F. Greenfield

Patient-Reported Changes in Alcohol Use Following Glucagon-Like Peptide-1 Receptor Agonist Initiation

This survey study with a nationally representative sample evaluates whether individuals who initiate glucagon-like peptide-1 receptor agonists (GLP-1 RAs) report reducing alcohol consumption after starting the drug.

Setting of Alcohol Use Disorder Diagnosis Among Women Enrolled in Medicare

OBJECTIVE: The authors assessed the setting of an initial diagnosis of alcohol use disorder among Medicare-enrolled women. METHODS: Using 2016-2022 Medicare fee-for-service claims, the authors identified the first alcohol use disorder diagnosis for women ages 18-64 years (N=116,2...